Historically, advancements in CHO-based recombinant protein production have been driven predominantly by process development, and whilst these efforts have delivered significant gains, they have also highlighted a need to optimize additional process inputs to accelerate platform development.

We analyzed ~300 launches to identify the factors most correlated with commercial success & built a framework for peak go-to-market performance.

Discover how leading biomanufacturers are rethinking buffer preparation with hybrid strategies that balance cost, flexibility, and efficiency. This white paper introduces a practical framework to help you evaluate, prioritize, and optimize buffer management decisions for long-term success.